Introduction
============

In the last years, the prevalence of fungal infections has increased significantly, especially in immunocompromised individuals, with concomitant life-threatening increments ([@B31]). Additionally, the epidemiology behind systemic fungal infections has changed. Indeed, bloodstream systemic infections (BSI) are mainly caused by *Candida* and *Aspergillus* species being *C. albicans*, *C. glabrata*, *C. parapsilosis*. *C. krusei* and *C. tropicalis* the most common infectiousagents for *Candida*-associated BSI, while *A. fumigatus*, *A. niger*, and *A. flavus* are responsible for the majority of *Aspergillus*-associated BSI ([@B25]). Regarding superficial mycoses, the major causal agents are dermatophytes that remain a health concern worldwide, in both immunocompromised and healthy individuals. This is mainly attributable to the resistance of fungi to conventional antifungal therapies as well as to high relapse rates ([@B15]).

For these reasons, fungal infections are still considered a serious problem worldwide that require effective therapeutic strategies. The most common antifungal agents used nowadays include fluconazole, amphotericin B and terbinafine. Nevertheless, these drugs have several reported adverse effects, such as nephrotoxicity and hepatotoxicity. Furthermore, they show a slow response in immunocompromised individuals ([@B21]) and have several therapeutic limitations, such as drug interactions, insufficient bioavailability and a fungistatic mechanism of action. In addition, development of resistance as well as innate resistance by emerging species have also been reported ([@B24]). Therefore, actual antifungal therapies are far from acceptable reinforcing the urgent need for the development of effective antifungal drugs.

Aromatic and medicinal plants, especially those belonging to Lamiaceae and Apiaceae families, have been used for centuries in traditional medicine for the treatment of several pathologies with many therapeutic effects being associated with the presence of volatile compounds, i.e., essential oils. In fact, these compounds have been described as bioactive agents, primarily due to their antifungal, antibacterial and anti-inflammatory properties ([@B8]; [@B48]; [@B2]). In many cases, the use of these plants/compounds is based on empiric knowledge. Thus, the spectrum of action as well as the underlying mechanisms of action are lacking and should be deeply explored.

The genus *Thymus*, one of the most relevant in the Lamiaceae family, includes *ca.* 215 species, many of them endemic to the Mediterranean region ([@B28]). Several thyme species are widely used in culinary as flavoring agents and show a pharmacological relevance in traditional medicine being used as spasmolytic, antiseptic, and expectorant agents ([@B40]; [@B28]). This genus is highly polymorphic regarding the chemical composition of its essential oils, which means that plants morphologically identical can chemically differ, allowing the identification of chemotypes. Indeed, several chemotypes have been identified, for example, in *Thymus vulgaris* ([@B44]), *Thymus zygis* subsp. *sylvestris* and subsp. *zygis*, *Thymus mastichina* subsp. *mastichina*, and *Thymus pulegioides* ([@B12]). The species *T. vulgaris* is one of the most polymorphic species within the genus ([@B44]).

Plants from the genus *Thymus* are known for their antifungal properties ([@B12]). Indeed *T. vulgaris* and *T. zygis* have a European Medicines Agency (EMA) monograph highlighting several effects including their antifungal ones ([@B17]). Moreover, several thyme species are used in traditional medicine, namely *T. zygis*, *T. mastichina*, *T. camphoratus*, *Thymus carnosus*, and *Thymus caespititius*. These species are often employed for the treatment of infections and inflammation of the mouth, pharynx, skin, and genital tract as well as for the relief of rheumatism ([@B32]; [@B4]; [@B29]; [@B38]). Regarding *T. camphoratus* and *T. carnosus*, both species are traditionally used in Portugal for the treatment of infections of the respiratory tract ([@B10]; [@B3]). Although some studies on their essential oil composition ([@B35], [@B37]) and biological effects have been reported ([@B11]; [@B9]; [@B47]), the knowledge regarding the antifungal potential of *T. camphoratus* and *T. carnosus* remains limited. Therefore, the present study was designed to unveil the antifungal activity of these essential oils and their major compounds against yeasts and filamentous fungi and concomitantly to elucidate the mechanisms of action underlying their potential antifungal effect. Importantly, the putative cytotoxicity of the essential oils to human keratinocytes was also assessed since this is a crucial step for further incorporation of these compounds in topical pharmaceutical formulations.

Materials and Methods {#s1}
=====================

Plant Material
--------------

Flowering aerial parts of *T. camphoratus* Hoffmanns. & Link (Lamiaceae) were collected in Lagos, Algarve, Portugal (N 37° 5′ 53″, W 8° 40′ 4″) whereas those of *T. carnosus* Boiss (Lamiaceae) were collected in Praia da Manta Rota, Algarve, Portugal (N 37° 9′ 49″, W 7° 31′ 7″), during Spring (June). Several plants were obtained to gather a representative sample. Voucher specimens were added to the Herbarium of the University of Coimbra (COI), with accession numbers L. Salgueiro 55 and L. Salgueiro 333 for *T. camphoratus* and *T. carnosus*, respectively. Species authenticity were confirmed by Dr. Jorge Paiva, a taxonomist at the University of Coimbra.

Essential Oil Isolation and Analysis
------------------------------------

The essential oils were obtained by hydrodistillation in a *Clevenger*-type apparatus and analyzed by gas chromatography (GC) and gas chromatography/mass spectrometry (GC/MS) using fused silica capillary columns with two different stationary phases: SPB-1 and SupelcoWax-10, as described by [@B5]. Volatile compounds were identified according to their GC retention indices on both SPB-1 and SupelcoWax-10 columns as well as mass spectra. Retention indices, calculated by linear interpolation relative to retention times of C~8~--C~23~ of *n*-alkanes, were compared with those of authentic products included in the Faculty of Pharmacy, University of Coimbra laboratory database (Faculty of Pharmacy, University of Coimbra) and/or literature data ([@B41]). Acquired mass spectra were compared with reference spectra from the laboratory database, Wiley/NIST library and literature data ([@B20]; [@B1]). Relative amounts of individual components were calculated based on GC raw data areas without FID response factor correction.

Antifungal Activity
-------------------

### Fungal Strains

The antifungal activity of the essential oils was evaluated against both reference and clinically isolated strains of several yeasts and filamentous fungi. Yeast strains included *Candida albicans* ATCC 10231, *C. guilliermondii* MAT23, *C. krusei* H9, *C. parapsilosis* ATCC 90018, *C. tropicalis* ATCC 13803, and *Cryptococcus neoformans* CECT 1078; Filamentous fungi namely dermatophyte and *Aspergilllus* strains were selected. Dermatophyte strains included *Epidermophyton floccosum* FF9, *Microsporum canis* FF1, *M. gypseum* CECT 2908, *Trichophyton mentagrophytes* FF7, *T. mentagrophytes* var. *interdigitale* CECT 2958, *T. rubrum* CECT 2794 and *T. verrucosum* CECT 2992 whereas *Aspergillus* strains were *A. flavus* F44, *A. fumigatus* ATCC 46645 and *A. niger* ATCC 16404.

The fungal isolates identified by standard microbiological methods were stored at --80°C on Sabouraud broth with 20% glycerol. Prior to testing, each isolate was inoculated on Sabouraud agar (SDA) to ensure optimal growth and purity.

### Fungal Growth (MIC and MFC)

Broth macrodilution methods based on the Clinical and Laboratory Standards Institute (CLSI) reference protocols M27-A3 ([@B7]) and M38-A2 ([@B6]) for yeasts and filamentous fungi, respectively, were used to determine the minimal inhibitory concentration (MIC) and minimal fungicidal concentration (MFC) of the essential oils and their major compounds (borneol, camphene, 1,8-cineole, α-pinene), as described previously ([@B48]). MICs were recorded as the lowest concentration of the essential oil/compound that inhibited fungal growth and MFCs were determined as the lowest concentration of the essential oil/compound able to kill the fungal strain. Two reference antifungal compounds, amphotericin B (Fluka, Buchs, Switzerland) and fluconazole (Pfizer, New York, United States), were used to control the sensitivity of the tested microorganisms. The experiments were performed at least in triplicates and a range of values presented whenever the results were not in agreement between replicates.

### *Candida albicans* Germ Tube Formation

To determine the effect of the essential oils and their major compounds on the yeast-mycelium transition, cell suspensions of *C. albicans* ATCC 10231, from overnight cultures on SDA, were prepared in NYP medium \[*N*-acetylglucosamine (Sigma; 10^−3^ mol/L), Yeast Nitrogen Base (Difco; 3.35 g/L), proline (Fluka; 10^−3^ mol/L), NaCl (4.5 g/L), and pH 6.7 ± 0.1 ([@B23])\]. The assay was then carried out as previously described by [@B27]. Briefly, *C. albicans* suspension was adjusted to a density of 1.0 ± 0.2 × 10^6^ CFU/mL and 990 μL of this suspension was distributed to test tubes. To each tube, 10 μL of sub-inhibitory concentrations of each essential oil and their major compounds were added and the cells were incubated without agitation for 3 h. Then, germ tube formation was registered under a light microscope (40×). Germ tubes were considered when the germinating protuberance was at least as long as the diameter of the blastopore. The conventional antifungal drug, fluconazole, was also tested and DMSO in a maximum concentration of 1% (v/v) was used as a control. The results are presented as the mean ± standard deviation (SD) of three independent experiments.

### Fungal Viability (MTT Assay)

The effect of the essential oils on *C. albicans* ATCC 10231 viability was determined using the MTT \[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide\] reduction assay ([@B27]) with slight modifications. Briefly, cell suspensions were prepared in RPMI and adjusted to a final density of 0.5--2.5 × 10^3^ CFU/Ml. The suspensions were then distributed into 12-well plates (1 mL/well) and incubated, without agitation, at 37°C. After 18--24 h of incubation, the cells were carefully homogenized, collected and centrifuged at 10,000 rpm for 5 min. Essential oils (0.07--0.57 mg/mL) were added to the pellets in a final volume of 1 mL and then the solutions were transferred to the microwell plate. Following an incubation at 37°C for 1 h, cells were harvested by centrifugation at 10,000 rpm for 5 min and 500 μL of 0.5 mg/mL of MTT (Sigma--Aldrich, St. Louis, MO, United States) in RPMI was added. After an incubation at 37°C for 30 min, the water-insoluble blue formazan crystals (viable cells) were solubilized with 300 μL of DMSO and measured spectrophotometrically at 510 nm using an ELISA microplate reader (SLT, Austria). An additional trypan blue exclusion assay was also performed to confirm the number of living cells.

### Biofilm Disruption

*Candida albicans* biofilm disruption assays were performed as previously reported ([@B43]). Briefly, a loop from a *C. albicans* culture in SDA grown for 24 h at 37°C was resuspended in Yeast Peptone Dextrose (YPD) broth (1% yeast extract, 2% peptone, and 2% dextrose) and further incubated for 24 h at 37°C. Then, cells were washed with PBS (pH 7.4) (0.8% NaCl, 0.02% KH~2~PO~4~, 0.31% Na~2~HPO~4~⋅12H~2~O, and 0.02% KCl). Cell density was adjusted to 1 × 10^6^ CFU/mL, and then 100 μL of this suspension was added to 96-well microtiter plates and incubated for 24 h at 37°C to allow biofilm adhesion and formation. Then, the wells were washed 3 times with PBS and the essential oils (0.28--2.2 mg/mL, prepared in RPMI) were added and incubated for 24 h, at 37°C. Essential oil-free wells, with DMSO in a maximum concentration of 1% (v/v), and biofilm-free wells were also included as positive and negative controls, respectively. Biofilm mass was quantified using crystal violet according to [@B30]. Briefly, after treatments and medium removal, biofilms were fixed with 99% methanol for 15 min. The supernatant was removed, and the wells air-dried. Then, a solution of crystal violet (0.02%) was added to each well and allowed to stain the biofilm for 15 min. Wells were washed 2--3 times with sterile distilled water. Absorbed stain was released by addition of 150 μL of acetic acid (33%) and transferred to fresh wells. The optical density (OD) was read at 620 nm using a microplate reader. The percentage of biofilm formation was calculated by comparing the OD of treated biofilm with that of control biofilm. Biofilm viability was assessed according to the method described by [@B34] with some modifications. Briefly, after the treatments, the medium was removed and 100 μL of a XTT (1 mg/mL in PBS) solution containing 4 μM of menadione (10 mM in acetone) was added to biofilms prewashed with PBS. After 2 h of incubation at 37°C in the dark, the absorbance was read at 490 nm. Biofilm viability was calculated by comparing the absorbance of treated samples with that of positive controls. Results are presented as mean ± SEM of three independent experiments performed in duplicate.

*In vitro* Cytotoxicity to Keratinocytes (MTT Assay)
----------------------------------------------------

The human keratinocytes cell line (HaCaT) was obtained from DKFZ (Heidelberg). Keratinocytes were cultured in Dulbecco's Modified Eagle Medium (high glucose) supplemented with 100 μg/mL streptomycin and 100 U/mL penicillin, 3.02 g/L sodium bicarbonate and 10% (v/v) inactivated fetal bovine serum, at 37°C in a humidified atmosphere of 95% air and 5% CO~2~. Evaluation of cell viability was performed by the colorimetric MTT assay, as previously reported. Quantification of formazan crystals was performed using an ELISA microplate reader at 570 nm with a reference wavelength of 620 nm. The results were expressed as the percentage of MTT reduction relatively to control cells.

Statistical Analysis
--------------------

Data are expressed as mean ± standard error (SEM) of the mean. Statistical significance was determined using one-way analysis of variance (ANOVA), followed by Dunnett's *post hoc* test. The statistical analysis was performed using Prism 5.0 Software (GraphPad Software). Differences were considered significant for *p* \< 0.05.

Results
=======

Essential Oil Composition
-------------------------

*Thymus camphoratus* and *T. carnosus* essential oils were obtained with yields of 1.4 and 1.8%, respectively (v/w). The identified volatile compounds accounted for a total amount of 92.5 and 90.1% of the oil for *T. camphoratus* and *T. carnosus*, respectively ([Table 1](#T1){ref-type="table"}). Both essential oils were characterized by high amounts of oxygen-containing monoterpenes being *T. carnosus* also rich in monoterpene hydrocarbons. The essential oil from *T. camphoratus* was characterized by high amounts of 1,8-cineole (15.5%), α-pinene (12.7%), borneol (8.5%), and camphene (6.6%; [Table 1](#T1){ref-type="table"} and [Supplementary Figure 1A](#SM1){ref-type="supplementary-material"}). *T. carnosus* essential oil was mostly rich in borneol (29.0%), camphene (19.5%), and α-pinene (8.9%; [Table 1](#T1){ref-type="table"} and [Supplementary Figure 1B](#SM1){ref-type="supplementary-material"}).

###### 

Essential oil composition of two Iberian *Thymus* spp.

  RI^†^                              RI^‡^   Ref RI^x^   Ref RI^\#^   Compound                 Essential oils   
  ---------------------------------- ------- ----------- ------------ ------------------------ ---------------- ------
  922                                1030    922         1030         α-Thujene                0.5              1.7
  928                                1025    930         1028         α-Pinene                 12.7             8.9
  941                                1072    943         1073         Camphene                 6.6              19.5
  959                                1447    959         1447         Oct-1-en-3-ol            --               t
  962                                1253    962         1253         Octan-3-one              --               t
  963                                1124    964         1126         Sabinene                 1.9              1.4
  968                                1115    969         1116         β-Pinene                 0.7              2.1
  980                                1159    980         1161         Myrcene                  0.2              0.1
  997                                1167    997         1168         α-Phellandrene           0.3              0.1
  1008                               1187    1010        1187         α-Terpinene              0.6              0.2
  1011                               1275    1011        1273         *p*-Cymene               0.3              3.5
  1019                               1204    1020        1205         Limonene                 1.5              1.3
  1020                               1215    1020        1214         β-Phellandrene           --               0.1
  1020                               1212    1020        1214         1,8-Cineole              15.5             0.4
  1025                               1235    1025        1235         *Z*-Ocimene              0.1              0.1
  1035                               1253    1035        1253         *E*-Ocimene              0.9              0.1
  1046                               1246    1046        1248         γ-Terpinene              0.3              0.9
  1050                               1459    1051        1459         *E*-Sabinene hydrate     0.2              0.3
  1055                               1438    1055        1439         *cis-*Linalool oxide     0.2              --
  1070                               1466    1070        1466         *trans*-Linalool oxide   0.2              --
  1077                               1284    1077        1288         Terpinolene              0.2              0.1
  1082                               1542    1080        1544         *Z*-Sabinene hydrate     0.6              2.1
  1084                               1539    1083        1542         Linalool                 5.0              0.2
  1106                               1488    1104        1487         α-Campholenal            0.4              0.2
  1109                               n.d.    1106        --           *Z*-p-Menth-2-en-1-ol    t                --
  1119                               1514    1118        1515         Camphor                  4.9              3.5
  1122                               1645    1119        1649         *E*-Pinocarveol          0.6              0.8
  1123                               1645    1122        1648         *Z*-Verbenol             0.1              --
  1129                               1668    1126        1672         *E*-Verbenol             1.1              1.1
  1136                               1564    1135        1562         Pinocarvone              0.3              --
  1145                               1691    1146        1695         Borneol                  8.5              29.0
  1158                               1845    1157        1845         *p*-Cymene-8-ol          0.3              0.2
  1160                               1594    1158        1595         Terpinene-4-ol           4.3              4.9
  1164                               1622    1165        1621         Myrtenal                 0.3              --
  1167                               1602    1167        1602         Dihydrocarvone           --               0.5
  1171                               1687    1169        1692         α-Terpineol              0.9              0.5
  1177                               1698    1177        1698         Verbenone                t                0.1
  1178                               1780    1177        1786         Myrtenol                 0.3              --
  1191                               1830    1192        1830         *E*-Carveol              0.4              t
  1211                               1728    1711        1727         Carvone                  0.2              --
  1214                               1679    1214        1679         Neral                    --               0.1
  1233                               1842    1233        1842         Geraniol                 0.3              t
  1264                               1580    1264        1578         Bornyl acetate           3.5              5.2
  1268                               2183    1267        2183         Thymol                   --               0.2
  1275                               2212    1275        2212         Carvacrol                --               0.1
  1324                               2159    1325        2163         Eugenol                  t                --
  1329                               1688    1328        1688         α-Terpinyl acetate       0.1              0.2
  1342                               1455    1342        1455         α-Cubebene               0.2              --
  1359                               1755    1359        1755         Geranyl acetate          0.8              --
  1376                               1517    1375        1517         β-Bourbonene             0.1              t
  1380                               1536    1380        1536         β-Cubebene               0.1              --
  1401                               1526    1401        1524         α-Gurjunene              --               0.1
  1407                               1591    1407        1590         *E*-caryophyllene        1.0              0.8
  1427                               1160    1428        1602         Aromadendrene            0.4              t
  1442                               1665    1442        1664         α-Humulene               --               t
  1447                               1636    1447        1637         Alloaromadendrene        --               0.1
  1466                               1699    1466        1699         Germacrene D             3.6              0.1
  1482                               1726    1482        1726         Bicyclogermacrene        0.2              --
  1495                               1723    1495        1723         β-Bisabolene             0.1              --
  1502                               1752    1498        1752         γ-Cadinene               1.4              0.1
  1508                               1751    1508        1752         δ-Cadinene               1.1              --
  1529                               1768    1531        1767         α-Bisabolene             0.5              --
  1553                               2113    1552        2113         Spathulenol              --               t
  1559                               1971    1558        1968         Caryophyllene oxide      1.0              0.6
  1569                               2072    1598        2073         Viridiflorol             --               0.2
  1579                               2025    1582        2024         Ledol                    --               0.1
  1594                               2089    2596        2091         10-epi-γ-Eudesmol        0.5              t
  1607                               2158    1606        2158         γ-Eudesmol               --               0.1
  1615                               2153    1615        2160         τ-Cadinol                2.7              --
  1618                               2188    1615        2176         α-Muurolol               0.2              --
  1618                               2043    1620        2052         Cubenol                  0.3              --
  1622                               2215    1622        2215         β-Eudesmol               t                t
  1628                               2208    1622        2208         α-Eudesmol               --               0.1
  1628                               2218    1628        2221         α-Cadinol                t                --
  1659                               2210    1659        2209         α-Bisabolol              t                --
  Monoterpene hydrocarbons           26.8    40.1                                                               
  Oxygen containing monoterpenes     49.1    49.7                                                               
  Sesquiterpene hydrocarbons         8.7     1.4                                                                
  Oxygen containing sesquiterpenes   5.4     1.2                                                                
  Others                             0.1     0.1                                                                
  Total identified                   92.5    90.1                                                               

Compounds listed in order to their elution on the SPB-1 column; t = traces ≤0.05%.
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Antifungal Activity
-------------------

### Fungal Growth (MIC and MFC)

The antifungal activity (MICs and MFCs) of both essential oils and their main isolated compounds is presented in [Table 2](#T2){ref-type="table"}. Overall, both oils were more effective against *C. neoformans* with MIC values of 0.14 mg/mL and showed poor antifungal activity against the tested *Aspergillus* strains. For *Candida* spp., the essential oils of both species showed a slight fungicidal effect for most of the strains. For dermatophytes, both oils showed a fungicidal effect, but *T. camphoratus* was more effective than *T. carnosus*, presenting lower MIC values for most of the tested strains ([Table 2](#T2){ref-type="table"}).

###### 

Antifungal activity of *Thymus camphoratus* and *Thymus carnosus* essential oils and their major compounds against pathogenic yeasts, dermatophytes and *Aspergillus* strains.

                                                                 *T. camphoratus*   *T. carnosus*   Borneol   Camphene   α-Pinene   1,8-Cineole                                                                 
  -------------------------------------------------------------- ------------------ --------------- --------- ---------- ---------- ------------- ----------- ----------- ------------ ------------ ----------- -----------
  *Candida albicans* ATCC 10231                                  1.11--2.23         1.11--2.23      1.11      1.11       2.23       \>17.8        \>17.8      \>17.8      0.57--1.11   0.57--1.11   8.9         8.9
  *Candida guilliermondii* MAT23                                 2.23               2.23            1.11      1.11       2.23       \>17.8        \>17.8      \>17.8      1.11         1.11--2.23   17.8        17.8
  *Candida krusei* H9                                            2.23               2.23            2.23      2.23       4.5        \>17.8        \>8.9       \>17.8      0.14--0.28   0.28         8.9         8.9
  *Candida parapsilosis* ATCC 90018                              1.11               2.23            2.23      4.5        2.23       2.23          \>8.9       \>8.9       0.57         0.57         8.9         8.9
  *Candida tropicalis* ATCC 13803                                4.5                4.5             2.23      2.23       4.5        \>17.8        \>17.8      \>17.8      0.28         0.28         8.9         8.9
  *Cryptococcus neoformans* CECT 1078                            0.14               0.28            0.14      0.28       1.11       11.1          4.5         4.5         0.07         0.28         4.5--8.9    8.9
  *Epidermophyton floccosum* FF9                                 0.57               0.57            1.11      1.11       2.23       2.23          4.5         4.5         0.14         0.14         4.5         4.5
  *Microsporum canis* FF1                                        0.57               0.57            1.11      1.11       2.23       2.23          4.5         4.5         0.14         0.14--0.28   4.5         4.5
  *Microsporum gypseum* CECT 2908                                0.57               0.57--1.11      2.23      2.23       2.23       2.23          8.9         8.9         0.14         0.14         4.5--8.9    4.5--8.9
  *Trichophyton mentagrophytes* FF7                              0.57               0.57            1.11      1.11       2.23       4.5           4.5         4.5--8.9    0.28         0.28--0.57   4.5         4.5
  *Trichophyton mentagrophytes* var. *interdigitale* CECT 2958   1.11               1.11            1.11      2.23       2.23       4.5           8.9--17.8   8.9--17.8   0.28         0.28         8.9         8.9
  *Trichophyton verrucosum* CECT 2992                            1.11               1.11            2.23      2.23       2.23       2.23          17.8        17.8        1.11         1.11         8.9         8.9--17.8
  *Trichophyton rubrum* CECT 2794                                0.57               0.57            0.57      1.11       2.23       2.23          2.23--4.5   4.5         0.07         0.07         2.23--4.5   4.5
  *Aspergillus flavus* F44                                       4.5                \>8.9           4.5       \>8.9      4.5        \>17.8        \>17.8      \>17.8      1.11         1.11         17.8        17.8
  *Aspergillus fumigatus* ATCC 46645                             2.23               \>8.9           2.23      8.9        2.23       \>17.8        \>17.8      \>17.8      1.1          1.11--223    8.9         8.9--17.8
  *Aspergillus niger* ATCC 16404                                 2.23               \>8.9           2.23      \>17.8     4.5        \>17.8        \>17.8      \>17.8      2.23         4.5          8.9         \>17.8

†

MIC and MFC were determined by a macrodilution method and expressed in mg/mL. Results were obtained from 3 independent experiments performed in duplicate.

Regarding the antifungal activity of the isolated compounds, α-pinene was, by far, the most effective compound ([Table 2](#T2){ref-type="table"}). Indeed, α-pinene showed a fungicidal effect for most of the tested strains, being very effective against *C. neoformans* and *T. rubrum* (MIC = 0.07 mg/mL). Contrarily, 1,8-cineole and camphene were ineffective against many of the tested strains, while borneol showed a slight antifungal effect (MIC ranging from 1.11 to 4.5 mg/mL; [Table 2](#T2){ref-type="table"}).

### Germ Tube Inhibition in *Candida albicans*

Since the yeast-to-hypha transition is an important virulence factor associated with the pathogenesis of *C. albicans* infections, the effect of the oils on the germ tube formation in *C. albicans* ATCC 10231 was assessed. As shown in [Table 3](#T3){ref-type="table"}, both essential oils inhibited the germ tube formation at concentrations well below their respective MIC, with *T. camphoratus* being more effective and attaining ca. 40% inhibition at 0.07 mg/mL (MIC/16). Fluconazole (MIC = 0.001 mg/mL), the antifungal drug of choice in the clinic for the management of candidiasis, failed to inhibit this feature even at concentrations much higher than its MIC. Indeed, even at 0.2 mg/mL, that corresponds to fluconazole's MIC×200 ([Table 4](#T4){ref-type="table"}), the antifungal drug was completely ineffective.

###### 

Effect of sub-inhibitory concentrations of the essential oil of *Thymus camphoratus*, *Thymus carnosus* and their major compounds on the germ tube formation of *Candida albicans* ATCC 10231.

            *T. camphoratus*   *T. carnosus*      α-Pinene           Borneol            1,8-Cineole       Camphene
  --------- ------------------ ------------------ ------------------ ------------------ ----------------- ------------------
  0.02^‡^   91.7 ± 3.0^∗∗^     98.1 ± 1.7         --                 --                 --                --
  0.04      81.9 ± 1.2^∗∗∗∗^   90.3 ± 2.2         93.2 ± 0.8         93.1 ± 2.3         --                --
  0.07      62.0 ± 2.1^∗∗∗∗^   79.7 ± 2.8^∗∗∗^    86.3 ± 0.7^∗^      89.2 ± 2.5         --                --
  0.14      43.1 ± 5.3^∗∗∗∗^   47.1 ± 4.9^∗∗∗∗^   55.7 ± 7.0^∗∗∗∗^   76.6 ± 4.3^∗∗∗∗^   --                --
  0.28      11.3 ± 2.2^∗∗∗∗^   7.3 ± 2.6^∗∗∗∗^    4.9 ± 1.8^∗∗∗∗^    58.7 ± 4.0^∗∗∗∗^   85.7 ± 7.1        91.8 ± 0.5
  0.57      0.0 ± 0.0^∗∗∗∗^    0.0 ± 0.0^∗∗∗∗^    0.0 ± 0.0^∗∗∗∗^    29.6 ± 2.1^∗∗∗∗^   66.7 ± 1.2^∗∗^    74.5 ± 7.3
  1.11      --                 --                 --                 4.5 ± 0.9^∗∗∗∗^    29.4 ± 3.2^∗∗∗^   48.4 ± 12.9^∗^
  2.23      --                 --                 --                 --                 1.2 ± 0.1^∗∗∗∗^   10.0 ± 6.6^∗∗∗∗^
  4.5       --                 --                 --                 --                 --                1.9 ± 1.9^∗∗∗∗^
  8.9       --                 --                 --                 --                 --                0.0 ± 0.0^∗∗∗∗^

†

Samples without essential oil, with 1% (v/v) DMSO.

‡

Absolute concentration of essential oil in mg/mL. Results are means ± SEM of a minimum of three independent experiments;

∗

p \< 0.05,

∗∗

p \< 0.01,

∗∗∗

p \< 0.001,

∗∗∗∗

p \< 0.0001, compared to control (100%).

###### 

Effect of sub-inhibitory concentrations of fluconazole on the germ tube formation of *Candida albicans* ATCC 10231.

             *Fluconazole*
  ---------- ---------------
  0.200^‡^   89.10 ± 5.09
  0.128      90.04 ± 9.94
  0.004      98.86 ± 6.07
  0.002      100.53 ± 7.81
  0.001      101.00 ± 5.27

†

Sample without fluconazole, with 1% (v/v) DMSO.

‡

Absolute concentration of fluconazole in mg/mL. Results are means ± SEM of a minimum of three independent experiments.

The effect of the isolated major compounds, namely borneol, camphene, 1,8-cineole and α-pinene was also considered to assess which of these compounds could contribute to the activity of the oils. Our results show that both essential oils have a stronger effect on the inhibition of the germ tube formation in comparison to the isolated major compounds. Remarkably, although α-pinene showed lower MIC and MFC values than the essential oil ([Table 2](#T2){ref-type="table"}), our results demonstrate that both essential oils affect *C. albicans* germ tube formation at lower concentrations than α-pinene ([Table 3](#T3){ref-type="table"}).

### *Candida albicans* Viability

The effect of the essential oils on *C. albicans* viability was also assessed ([Figure 1](#F1){ref-type="fig"}). Once again, our results show that both oils inhibited *C. albicans* mitochondrial activity at concentrations lower than their respective MIC. Nevertheless, *T. carnosus* essential oil showed better results since it significantly reduced *C. albicans* mitochondrial activity at concentrations ranging from 0.07 to 0.57 mg/mL. Indeed, a viability decrease of more than 70% was observed at 0.28 mg/mL for *T. carnosus* essential oil whereas *T. camphoratus* oil decreased cell viability of the yeast only *ca*. 44% at 0.57 mg/mL and at lower concentrations (≤0.28 mg/mL) was ineffective ([Figure 1](#F1){ref-type="fig"}). A trypan blue exclusion assay, that assesses the integrity of the cell wall, showed 100% of living fungi cells in all the tested concentrations (data not shown), thus confirming the adverse effect on the essential oils directly on mitochondrial activity.

![Viability of *C. albicans* ATCC 10231 cells treated with different concentrations of *Thymus camphoratus* and *Thymus carnosus* essential oils. One-way ANOVA was performed separately for each species and values are expressed as % of mitochondrial activity relative to control (mean ± SEM of three independent assays). ^∗∗^*p* \< 0.01, ^∗∗∗^*p* \< 0.001, ^∗∗∗∗^*p* \< 0.0001, compared to control.](fphar-10-00446-g001){#F1}

### Disruption of Preformed Biofilms in *Candida albicans*

Bearing in mind that *C. albicans* biofilms are also important virulence factors, the capacity of the essential oils to decrease both biofilm mass ([Figure 2A](#F2){ref-type="fig"}) and biofilm viability ([Figure 2B](#F2){ref-type="fig"}) were also assessed. Overall, both oils were effective at concentrations close to their respective MIC ([Figure 2](#F2){ref-type="fig"}), with *T. carnosus* essential oil being slightly more active in reducing biofilm viability since it decreased this feature at MIC/2 (0.57 mg/mL; [Figure 2B](#F2){ref-type="fig"}). Interestingly, fluconazole was ineffective in decreasing biofilm biomass showing a slight effect in biofilm viability reduction at concentrations much higher than its MIC (MIC×128; data not shown).

![*Candida albicans* ATCC 10231 biofilm biomass **(A)** and biofilm viability **(B)**. Cells were treated with different concentrations of *Thymus camphoratus* and *Thymus carnosus* essential oil. Biofilm mass was quantified by the crystal violet assay and biofilm viability assessed using the XTT assay. One-way ANOVA was performed separately for each species and values are expressed as a percentage of biofilm biomass or viability relative to control (mean ± SEM of three independent assays). ^∗^*p* \< 0.05, ^∗∗^*p* \< 0.01, ^∗∗∗^*p* \< 0.001, ^∗∗∗∗^*p* \< 0.0001, compared to control. "+" indicates MIC values of the essential oils.](fphar-10-00446-g002){#F2}

Cytotoxicity of the Essential Oils
----------------------------------

*Thymus carnosu*s essential oil was slightly more toxic (IC~50~ = 0.705 mg/mL) than *T. camphoratus* oil (IC~50~ = 0.848 mg/mL). Nevertheless, at bioactive concentrations, against the majority of the dermatophyte strains, as well as at concentrations that inhibited *C. albicans* germ tube formation, no toxicity was observed, thus pointing out a safety profile for a further development of topical formulations ([Table 5](#T5){ref-type="table"}). Additionally, at lower concentrations (below 0.28 mg/mL) both essential oils increased cell viability ([Table 5](#T5){ref-type="table"}). This could be due to an increase in keratinocytes proliferation or due to the stimulation of their mitochondrial activity and therefore, additional studies should be conducted to further understand this event.

###### 

Effect *of Thymus camphoratus* and *Thymus carnosus* essential oils on keratinocytes viability.

  Essential oil                                 Concentration (mg/mL)   Keratinocytes HaCaT (% of control)
  --------------------------------------------- ----------------------- ------------------------------------
  *Thymus camphoratus* (IC~50~ = 0.953 mg/mL)   1.11                    54.03 ± 8.42
                                                0.57                    96.81 ± 4.91
                                                0.28                    127.2 ± 25.62
                                                0.14                    146.8 ± 29.70
                                                0.07                    134.6 ± 20.33
  *Thymus carnosus* (IC~50~ = 0.793 mg/mL)      1.11                    44.05 ± 4.48^∗^
                                                0.57                    82.56 ± 1.31
                                                0.28                    103.2 ± 18.94
                                                0.14                    107.4 ± 13.71
                                                0.07                    122.6 ± 21.88

Results are expressed as percentage of MTT reduction relatively to control cells maintained in culture medium. Each value represents mean ± SEM of at least three independent experiments performed in duplicate. Statistical differences compared to control cells (100%).

∗

p \< 0.05, using a one-way ANOVA followed by a Dunnett's multiple comparison test.

Discussion
==========

Previous studies on the chemical composition of *T. camphoratus* and *T. carnosus* essential oils reported some chemical variability,as frequently shown for other thyme species. For example, [@B37] studied different populations of *T. camphoratus* collected in Algarve and Baixo Alentejo (south of Portugal) and showed a high chemical variability, particularly among individual samples or small populations, being α-pinene (7.0--11.0%), borneol (1.0--24.0%), and 1,8-cineole (3.9--20.0%) the major compounds identified. In another study, the essential oils from both flowers and leaves of *T. camphoratus* collected in Algarve, Portugal, showed very high amounts of 1,8-cineole, 56.7 and 62.7% for flowers and leaves, respectively ([@B11]). Similarly, for *T. carnosus* of different regions of Algarve and Baixo Alentejo, Portugal, a chemical variability was observed between the samples. Nevertheless, most of the essential oils were characterized by high amounts of borneol (23.0--32.0%), camphene (6.0--13.0%), terpinen-4-ol (4.0--12.2%), and *cis*-sabinene hydrate (2.5--10.7%) ([@B35]). In our study, plants growing in large populations of the Algarve region (Portugal) were collected for essential oil extraction, therefore, the chemical profile described is the most prevalent in *T. carnosus* and *T. camphoratus* growing in the south of Portugal. Furthermore, Stahl-Biskup ([@B40]) described that thymol and carvacrol, both terpene phenols, as well as their biogenetic derivatives are important compounds in the genus *Thymus*, followed by linalool, borneol, terpinen-4-ol, and 1,8-cineole. Indeed, thymes rich in 1,8-cineole, such as *T. mastichina* have a very high industrial interest, having an ISO monograph ([@B19]), thus highlighting the potential industrial interest for the species herein described.

Studies on the antifungal activity of *T. camphoratus* and *T. carnosus* essential oils are scarce and based upon different methodologies. Indeed, previous studies using the disk diffusion method, showed a weak or even no inhibitory effect of both oils on *C. albicans* ([@B11]; [@B9]). Regarding the antifungal potential of other thyme species with high amounts of 1,8-cineole, some studies have been reported. For example, the essential oils of *T. mastichina* and *T. capitellatus* ([@B26]; [@B36]) showed a weaker antifungal effect against several yeasts, dermatophytes and *Aspergillus* strains compared with the oils tested in the present study. In opposition, the essential oil from *T. herba-barona* ([@B48])*, T. zygis* subsp. *sylvestris* ([@B26]), *T. zygis* subsp. *zygis* ([@B14]), and *T. vulgaris* ([@B26]) showed a more preeminent activity due to their high content in phenolic terpenoids, namely thymol and/or carvacrol. In the present study, the antifungal effect of the essential oils could be mainly attributed to α-pinene since it was found in considerable amounts in both oils. Nevertheless, active minor compounds may also contribute to the activity of the essential oil. For example, linalool, cadinol, and terpinen-4-ol, all minor compounds of both *T. carnosus* and *T. camphoratus* essential oils, have also been widely described as antifungal agents ([@B27]; [@B42]) and an anti-yeast addictive effect has been reported for α-pinene and limonene ([@B45]).

To the best of our knowledge, the present study is the first report on the effect of *T. camphoratus* and *T. carnosus* essential oils on *C. albicans* germ tube formation. Assessing this feature is of great relevance since the yeast-to-hypha transition represents the main virulence factor associated with candidosis. Also, filamentation is essential for the development of robust biofilms, another major virulence factor associated with the pathogenesis of *C. albicans* ([@B33]). Indeed, fluconazole, the main antifungal used in the clinic, is ineffective on germ tube inhibition. Our findings show that very low doses of the essential oils are able to inhibit filamentation in *C. albicans*, being more effective than the isolated compounds tested. The stronger effect of the essential oils may be explained by the presence of active minor compounds. Indeed, linalool, a minor compound in both oils has been described as an effective natural compound for inhibiting germ tube formation in *C. albicans* ([@B18]). Regarding other thyme species, few studies have demonstrated inhibitory effects, but with variable results between species. Interestingly, although phenolic thyme essential oils, such as those from *T. vulgaris* and *T. zygis*, show potent antifungal activities they are much less effective in inhibiting *C. albicans* germ tube formation than *T. camphoratus* and *T. carnosus* oils. Indeed *T. vulgaris* and *T. zygis* essential oils were only able to achieve significant inhibitions of filamentation (over 50%) at MIC values (0.16--0.32 μL/mL) ([@B26]), whereas *T. camphoratus* essential oil attained about 40% of inhibition at much lower concentrations (0.07 mg/mL) and at MIC/4, ca. 90% of inhibition was observed ([Table 3](#T3){ref-type="table"}).

Regarding *C. albicans* viability, once again, as far as it is known, the present study is the first to report the effect of *T. camphoratus* and *T. carnosus* oils on *C. albicans* mitochondrial activity. Previously, other thyme essential oils were tested, namely *T. villosus* subsp. *lusitanicus*. Nevertheless, contrarily to our results, only detrimental effects were observed at concentrations close to the respective MIC ([@B27]). Moreover, both *T. camphoratus* and *T. carnosus* essential oils were effective in disrupting *C. albicans* biofilms, being *T. carnosus* oil slightly more active in reducing yeast viability. It is well known that, similarly to bacteria, fungi in biofilms show a higher resistance toward antifungals than planktonic fungi, due to the expression of several resistance genes and phenotypic modifications. Indeed, *C. albicans* biofilms have been reported as highly resistant to fluconazole ([@B46]). Therefore, the disruption of this highly organized system is a very attractive target for the development of effective antifungals ([@B2]). It is important to emphasize that studies evaluating the effect of thyme essential oils on preformed biofilms are lacking. Nevertheless, regarding isolated compounds, several terpenes found in *T. carnosus* and *T. camphoratus* essential oil have been previously tested. Some compounds such as 1,8-cineole showed an inhibitory effect at high concentrations, 8 mg/mL ([@B16]). Moreover, several other compounds showed an inhibitory effect on the biofilm formation, namely camphor, camphene, and borneol ([@B22]) as well as α-pinene ([@B39]). Furthermore, linalool, a minor compound found in both oils, was able to disrupt preformed *C. albicans* biofilms ([@B18]; [@B30]) and terpinen-4-ol was able to disrupt preformed single and dual-species *Candida* biofilms in a dose-dependent manner ([@B13]).

Taken together these results show that *T. camphoratus* and *T. carnosus* essential oils have anti-virulent potential, thus preventing disseminative candidosis.

Bearing in mind a future topical application that is more amenable and shows fewer side effects than oral or intranasal applications, the effect of the essential oil on keratinocytes was assessed, with no toxicity observed at pharmacological relevant concentrations.

Conclusion
==========

This study highlights the antifungal potential of two Iberian endemic thyme species: *T. camphoratus* and *T. carnosus*. Of relevance, the results demonstrated that both oils were able to inhibit the growth of *Cryptococcus neoformans* and several dermatophyte strains. Moreover, the oils were very effective in inhibiting *C. albicans* germ tube formation at concentrations well below the MIC and in a much higher extend than fluconazole, an antifungal drug widely used in the clinic. Finally, *T. carnosus* oil was more effective in decreasing yeast mitochondrial activity and disrupting preformed biofilms in *C. albicans*. Overall, our results point out promising anti-virulent effects for these oils, foreseeing a potential application in the management of disseminative candidiasis.

Our findings add relevant information to the pharmacological activity of these species concomitantly providing new insights to their mechanism of action and reinforcing the use of thyme plants as topical antiseptics and disinfectants, since toxicity towards keratinocytes was absent at most of the bioactive concentrations. In addition to the relevant antifungal activity, both thymes have a very good essential oil yield, which increases their commercial interest and industrial potential. Overall, our results raise awareness on species poorly recognized and valued, thus paving the way for a better industrial exploitation of these plants namely in the pharmaceutical field.
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